Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours

by Doi, T, Ohtsu, A, Yoshino, T, Boku, N, Onozawa, Y, Fukutomi, A, Hironaka, S, Koizumi, W, Sasaki, T
Published 2012

Inter-institutional heterogeneity in outcomes of chemotherapy for metastatic gastric cancer: correlative study in the JCOG9912 phase III trial

by Kurokawa, Y, Boku, N, Yamaguchi, T, Ohtsu, A, Mizusawa, J, Nakamura, K, Fukuda, H
Published 2016

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

by Mochizuki, I, Takiuchi, H, Ikejiri, K, Nakamoto, Y, Kinugasa, Y, Takagane, A, Endo, T, Shinozaki, H, Takii, Y, Takahashi, Y, Mochizuki, H, Kotake, K, Kameoka, S, Takahashi, K, Watanabe, T, Watanabe, M, Boku, N, Tomita, N, Matsubara, Y, Sugihara, K
Published 2012

A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer†

by Ueno, M., Okusaka, T., Omuro, Y., Isayama, H., Fukutomi, A., Ikeda, M., Mizuno, N., Fukuzawa, K., Furukawa, M., Iguchi, H., Sugimori, K., Furuse, J., Shimada, K., Ioka, T., Nakamori, S., Baba, H., Komatsu, Y., Takeuchi, M., Hyodo, I., Boku, N.
Published 2016

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

by Yoshida, M., Ishiguro, M., Ikejiri, K., Mochizuki, I., Nakamoto, Y., Kinugasa, Y., Takagane, A., Endo, T., Shinozaki, H., Takii, Y., Mochizuki, H., Kotake, K., Kameoka, S., Takahashi, K., Watanabe, T., Watanabe, M., Boku, N., Tomita, N., Nakatani, E., Sugihara, K.
Published 2014